Especially, we detected the significant correlation between survival and HSDL2 expression in the patients with both early and late stage (Figures S1A,B and Figure 2C,D), lymph node metastasis and no metastasis (Figure 2E,F and Figure S1C,D). Here, HSDL2 is linked to metastatic malignant neoplasm in the lymph nodes.